NM404 as an Imaging Agent in Patients With Non-small Cell Lung Cancer (NSCLC)
Phase of Trial: Phase I
Latest Information Update: 23 May 2019
Price : $35 *
At a glance
- Drugs CLR 1404 I-124 (Primary) ; CLR 1404 I-131 (Primary)
- Indications Non-small cell lung cancer
- Focus Diagnostic use
- 20 May 2019 Status changed from active, no longer recruiting to completed.
- 18 Sep 2015 Study design is changed from Interventional to observational also number of treatment arms changed from 2 to 1 as reported by ClinicalTrials.gov record.
- 18 Sep 2015 Status changed from recruiting to active, no longer recruiting as reported byClinicalTrials.gov record.